Novel Mucoadhesive Polymers for Nasal Drug Delivery

The use of nasal cavity as a route of administration of drugs, specifically systemically acting drugs that pose a delivery challenge, have become an area of great interest to the pharmaceutical companies in the past decade. The physiology of the nasal cavity allows for variety of drug delivery possibilities and destinations which include local, systemic, vaccine, and access to the central nervous system (CNS)[1]

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  2012-10-31

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.5772/52560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration.

  2012cited by this paper
• Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations

  2012cited by this paper
• Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels

  2012cited by this paper
• Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route.

  2012cited by this paper
• Intranasal drug delivery system- A glimpse to become maestro

  2011cited by this paper
• Alginate-PEGAc: a new mucoadhesive polymer.

  2011cited by this paper
• Drug Delivery: Plant Lectins as Bioadhesive Drug Delivery Systems

  2011cited by this paper
• Nose-to-Brain Transport Pathways of Wheat Germ Agglutinin Conjugated PEG-PLA Nanoparticles

  2011cited by this paper
• Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.

  2011cited by this paper
• Physical and structural characteristics of acrylated poly(ethylene glycol)-alginate conjugates.

  2011cited by this paper
• Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

  2011cited by this paper
• Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines

  2011cited by this paper
• Novel Mucoadhesive Polymers -A Review

  2011cited by this paper
• Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system

  2010cited by this paper
• Preparation of nasal temperature-sensitive in situ gel of Radix Bupleuri and evaluation of the febrile response mechanism

  2010cited by this paper
• Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.

  2010cited by this paper
• Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188.

  2010cited by this paper
• Polymers in Mucoadhesive Drug-Delivery Systems: A Brief Note

  2009cited by this paper
• Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

  2009cited by this paper
• Mucoadhesive polymeric platforms for controlled drug delivery.

  2009cited by this paper
• Intranasal drug delivery: how, why and what for?

  2009influential reference
• Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula).

  2008cited by this paper
• Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.

  2007influential reference
• Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.

  2007cited by this paper
• In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin

  2006cited by this paper
• A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics

  2006cited by this paper
• Thermoreversible-mucoadhesive Gel for nasal delivery of sumatriptan

  2006cited by this paper
• Novel alginate-acrylic polymers as a platform for drug delivery.

  2006cited by this paper
• PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.

  2006cited by this paper
• In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.

  2006cited by this paper
• Thiomers: a new generation of mucoadhesive polymers.

  2005cited by this paper
• Comparison of the mucoadhesive properties of various polymers.

  2005cited by this paper
• Nasal drug administration: potential for targeted central nervous system delivery.

  2005cited by this paper
• Mucoadhesive polymers: strategies, achievements and future challenges.

  2005cited by this paper
• Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.

  2005cited by this paper
• Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone.

  2004cited by this paper
• Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors

  2004cited by this paper
• Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli

  2004cited by this paper
• Thiomers: potential excipients for non-invasive peptide delivery systems.

  2004cited by this paper
• Pluronic gels for nasal delivery of Vitamin B12. Part I: preformulation study.

  2004cited by this paper
• Alginate Gelation Technologies

  2004cited by this paper
• Intranasal delivery: An approach to bypass the blood brain barrier

  2004cited by this paper
• Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans.

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003influential reference
• Bioadhesive microspheres as a controlled drug delivery system.

  2003cited by this paper
• Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.

  2003cited by this paper
• The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers

  2002cited by this paper
• Nasal drug delivery: new developments and strategies.

  2002cited by this paper
• Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery.

  2002cited by this paper
• Effect of additives on the micellization of PEO/PPO/PEO block copolymer F127 in aqueous solution

  2001cited by this paper
• ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.

  2001cited by this paper
• Lectin-mediated mucosal delivery of drugs and microparticles.

  2000cited by this paper
• Bioadhesive-based dosage forms: the next generation.

  2000cited by this paper
• Effect of Salts on the Micellization, Clouding, and Solubilization Behavior of Pluronic F127 Solutions.

  2000cited by this paper
• Lectin-mediated drug delivery: the second generation of bioadhesives.

  2000cited by this paper
• Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages.

  2000cited by this paper
• Lectins in drug delivery: a study of the acute local irritancy of the lectins from Solanum tuberosum and Helix pomatia.

  1999cited by this paper
• Bacterial ghosts as drug carrier and targeting vehicles.

  1999cited by this paper
• Effect of phi X174 protein E-mediated lysis on murein composition of Escherichia coli.

  1998cited by this paper
• Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels

  1997cited by this paper
• Bacterial adhesins as a drug carrier: covalent attachment of K99 fimbriae to 6-methylprednisolone.

  1997cited by this paper
• Bacterial ghosts as multifunctional vaccine particles.

  1997cited by this paper
• A review of: “Nonionic Surfactants, Polyoxyalkylene Block Copolymers”, V. M. Nace, Ed, (Surfactant Science Series Volume 60), Marcel Dekker, NY, 1996.

  1997cited by this paper
• Nonionic Surfactants: Polyoxyalkylene Block Copolymers

  1996cited by this paper
• Gelatine gels and polyoxyethylene-polyoxypropylene gels : comparative study of their properties

  1994cited by this paper
• Effect of Formulation Additives upon the Intranasal Bioavailability of a Peptide Drug: Tetracosactide (ACTH1−24)

  1994cited by this paper
• The aggregation behavior of poly-(oxyethylene)-poly-(oxypropylene)-poly-(oxyethylene)-block-copolymers in aqueous solution

  1990cited by this paper
• Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E

  1990cited by this paper
• Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.

  1987cited by this paper
• Bioadhesive microspheres as a potential nasal drug delivery system

  1987cited by this paper
• Occluding junction structure-function relationships in a cultured epithelial monolayer

  1985cited by this paper
• Rheological properties of poloxamer vehicles

  1984cited by this paper
• Monomers and Polymers

  1973cited by this paper
• Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns.

  1972cited by this paper

• Intranasal nanoparticulate drug delivery systems for neurodegenerative disorders: an Overview

  2025cites this paper
• A comprehensive review on natural polysaccharides based in situ gels for nasal drug delivery.

  2025cites this paper
• Role of natural plant extracts and hyaluronic acid derivatives in intranasal strategies for brain delivery. A review.

  2025cites this paper
• Transmucosal drug delivery: prospects, challenges, advances, and future directions

  2025cites this paper
• Promising brain biodistribution of insulin via intranasal dry powder for nose-to-brain delivery

  2024cites this paper
• Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review

  2024cites this paper
• Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update

  2023cites this paper
• Nasal delivery as a strategy for the prevention and treatment of COVID-19

  2023cites this paper
• Nose-to-Brain delivery of donepezil hydrochloride following administration of an HPMC-Me-β-CD-PEG400 nasal film in mice

  2023cites this paper
• Development and In Vitro-Ex Vivo Evaluation of Novel Polymeric Nasal Donepezil Films for Potential Use in Alzheimer’s Disease Using Experimental Design

  2022cites this paper
• Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy

  2022cites this paper
• Nose to brain delivery of drugs for CNS diseases

  2021cites this paper
• Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms

  2021cites this paper
• Mucoadhesive Delivery System: A Smart Way to Improve Bioavailability of Nutraceuticals

  2021cites this paper
• Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery

  2021cites this paper
• Nose to Brain Drug Delivery System

  2021cites this paper
• REPURPOSING MUCOADHESIVE DRUG DELEVERY SYSTEM: ADVANCEMENTS AND FUTURE PROSPECTS

  2021cites this paper
• Design and development of thiolated graphene oxide nanosheets for brain tumor targeting

  2020cites this paper
• Stability study of nasal powder formulation containing nanosized lamotrigine

  2020cites this paper
• University of Szeged

  2020cites this paper
• Nasal Bioadhesive Drug Delivery Systems and Their Applications

  2020cites this paper
• Development of Donepezil Hydrochloride Loaded Gellan Gum Based Nasal Mucoadhesive Microspheres by Spray Drying Method

  2020cites this paper
• Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?

  2019cites this paper
• Formulation of levodopa containing dry powder for nasal delivery applying the quality‐by‐design approach

  2018cites this paper
• Synthesis and characterization of thiolated hexanoyl glycol chitosan as a mucoadhesive thermogelling polymer

  2018cites this paper
• Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study

  2017cites this paper
• Evaluation of intranasal administration of fluoroquinolones and their potential in the treatment of chronic rhinosinusitis: ciprofloxacin and levofloxacin

  2017cites this paper
• A SYSTEMATIC REVIEW ON MUCOADHESIVE DRUG DELIVERY SYSTEM

  2017cites this paper
• Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery

  2016cites this paper
• Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery

  2016cites this paper
• NOVEL APPROACH FOR NOSE-TO-BRAIN DRUG DELIVERY BYPASSING BLOOD BRAIN BARRIER BY PRESSURIZED OLFACTORY DELIVERY DEVICE

  2015cites this paper
• Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.

  2015cites this paper
• Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.

  2015cites this paper
• Background of the Problem Selected for the Research

  2015cites this paper
• Mucus as Physiological Barrier to Intracellular Delivery

  2014cites this paper